Bristol-Myers Squibb Gains NMPA Approval for Opdivo-Yervoy Combo in NSCLC
CompanyDrug

Bristol-Myers Squibb Gains NMPA Approval for Opdivo-Yervoy Combo in NSCLC

NMPA Updates 2025 Edition of Medical Narcotic and Psychotropic Substances Catalogs
Policy / Regulatory

NMPA Updates 2025 Edition of Medical Narcotic and Psychotropic Substances Catalogs

Tibet Aim Pharm's Major Shareholder Transfers Stake to Beijing Fuhao
CompanyDeals

Tibet Aim Pharm’s Major Shareholder Transfers Stake to Beijing Fuhao

Roche's Elevidys Receives Negative CHMP Opinion for Duchenne Muscular Dystrophy
CompanyDrug

Roche’s Elevidys Receives Negative CHMP Opinion for Duchenne Muscular Dystrophy

Aidea Pharma's Aitribond Approved by Zanzibar Food and Drug Agency
CompanyDrug

Aidea Pharma’s Aitribond Approved by Zanzibar Food and Drug Agency

Mirxes and NAGAWA Launch Free Gastric Cancer Screening Project in Japan
CompanyDeals

Mirxes and NAGAWA Launch Free Gastric Cancer Screening Project in Japan

Ascletis Pharma Doses First Patients in U.S. Phase 2a Trial for Monthly GLP-1 Agonist ASC30
CompanyDrug

Ascletis Pharma Doses First Patients in U.S. Phase 2a Trial for Monthly GLP-1 Agonist ASC30

Sobi North America's Doptelet Approved by FDA for Pediatric ITP Treatment
CompanyDrug

Sobi North America’s Doptelet Approved by FDA for Pediatric ITP Treatment

Hengrui and GSK Enter Global Licensing Pact for PDE3/4 Inhibitor HRS-9821
CompanyDeals

Hengrui and GSK Enter Global Licensing Pact for PDE3/4 Inhibitor HRS-9821

Pfizer and BioNTech's LP.8.1 COVID-19 Vaccine Gets EMA CHMP Nod
CompanyDrug

Pfizer and BioNTech’s LP.8.1 COVID-19 Vaccine Gets EMA CHMP Nod

Sansure Biotech's Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification
CompanyMedical Device

Sansure Biotech’s Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification

NMPA Approves Ambroxol Hydrochloride Oral Drops for Over-the-Counter Sale
Policy / Regulatory

NMPA Approves Ambroxol Hydrochloride Oral Drops for Over-the-Counter Sale